Clinical Trial Update: Sedative Effect and Safety of Remimazolam Besylate in ARDS Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating sedative effect and safety of remimazolam besylate in patients with respiratory distress syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Remimazolam besylate (remimazolam besylate)

Snippet

Sponsor: Zhiming Jiang | Conditions: Respiratory Distress Syndrome | Phase 4 | Status: UNKNOWN